Monday is the fifth trading day since AMD disclosed a one-cent-strike warrant for up to 160 million shares — roughly ten percent of the company at a six-hundred-dollar share-price threshold — issued under the Meta six-gigawatt MI450 deal signed February 24. [1] The sell-side has not converged. JPMorgan's Harlan Sur has kept a constructive view, Goldman Sachs has held Neutral, and BofA's Vivek Arya has held Buy; the spread between the high and low price targets has not narrowed since Wednesday.

The paper's account of Day Four framed the warrant as a customer-funded balance-sheet event whose disclosure architecture would not surface until AMD's next 10-Q. Day Five does not change that. The deal calendar does. The first tranche vests on the deployment of one gigawatt of capacity, scheduled for the second half of 2026, which puts the first material warrant-accounting event inside the same trading week as Apple's record-day buyback execution today and Berkshire's first 13F under Greg Abel on Thursday. [2]

Meta's customer-shareholder posture is the unusual variable. Mark Zuckerberg's company will buy the chips, take warrants in the supplier, and disclose neither side of the accounting until the deployment trigger fires. [3] The Cerebras IPO pricing Wednesday at a band raised to a hundred-fifty to a hundred-sixty dollars sits on the same fiduciary-disclosure docket; both companies are pricing AI counterparty structure into the same trading week. The disciplined-cohort architecture this paper has tracked — Apple, Berkshire, Pfizer, AMD — meets its first vest-calendar test in the second half of the year. The sell-side spread says the price of that test is still being negotiated.

-- THEO KAPLAN, San Francisco